Robert Quinn, M.D.

Dr. Robert Quinn is currently Professor and Chair, Department of Orthopaedics at UT Health San Antonio, a position he has held since 2012. He was also Director of the Orthopaedic Residency Program until 2016. Prior to 2012 he was Vice Chair for Education and Residency Program Director at the University of New Mexico. His area of orthopaedic specialization is musculoskeletal oncology. Dr. Quinn is currently Chair of the Council on Research and Quality for the American Academy of Orthopaedic Surgeons, one of the highest leadership positions in that organization. He is past president of Musculoskeletal Tumor Society. He has published 85 peer-reviewed manuscripts, 16 textbook chapters, and a textbook on bone and soft tissue tumors. Dr. Quinn has held membership and leadership positions in multiple national organizations, professional societies, and multidisciplinary cancer research groups. He is a consultant reviewer for the Journal of Bone and Joint Surgery and Clinical Orthopaedics and Related Research. In addition to Orthopaedic Surgery, Dr. Quinn is actively involved in the specialty of Wilderness Medicine. He is an accomplished mountaineer. Dr. Quinn is a past president of the Wilderness Medical Society and a Fellow of the Academy of Wilderness Medicine. He has previously served on the editorial board of the Wilderness and Environmental Medicine Journal.

Publications

Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. J Bone Joint Surg Am. 2013 Oct 16;95(20):1887-95. Review. PubMed PMID: 24288805.

Verschraegen CF, Movva S, Ji Y, Schmit B, Quinn RH, Liem B, Bocklage T, Shaheen M. A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma. Cancers (Basel). 2013 Apr 11;5(2):418-29. doi:10.3390/cancers5020418. PubMed PMID: 24216984; PubMed Central PMCID: PMC3730334.